Dangers of the amyloid-β vaccination [1]

Acta Neuropathologica

Volumn 104, Issue 1, 2002, Pages 110-

  Smith, Mark A ^a   Joseph, James A ^a   Atwood, Craig S ^a   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; PROTEINASE;

AGING; ALZHEIMER DISEASE; DRUG SAFETY; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; LETTER; MEDICAL RESEARCH; NEUROPATHY; PRIORITY JOURNAL; PROTEIN FUNCTION; VACCINATION;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; HUMANS;

EID: 0036934298     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0572-2     Document Type: Letter

References (5)

1. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA (2001) Copernicus revisted: Amyloid β in Alzheimer's disease. Neurobiol Aging 22:131-146
2. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767
3. Perry G, Nunomura A, Raina AK, Smith MA (2000) Amyloid-β junkies. Lancet 355:757
4. Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein: A reanalysis of a therapeutic hypothesis. J Alzheimer's Dis 3:75-81
5. Smith MA, Joseph JA, Perry G (2000) Arson: tracking the culprit in Alzheimer's disease. Ann NY Acad Sci 924:35-38